Retracted: Naringenin Inhibits Cell Migration, Invasion, and Tumor Growth by Regulating circFOXM1/miR-3619-5p/SPAG5 Axis in Lung Cancer.

Tan Z, Sun Y, Liu M, Xia L, Cao F, Qi Y, Song Y

Open source

DOI
10.1089/cbr.2019.3520
Published
2020 Dec
Container
Cancer biotherapy & radiopharmaceuticals
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1089/cbr.2019.3520,
  title = {Retracted: Naringenin Inhibits Cell Migration, Invasion, and Tumor Growth by Regulating circFOXM1/miR-3619-5p/SPAG5 Axis in Lung Cancer.},
  author = {Tan Z and Sun Y and Liu M and Xia L and Cao F and Qi Y and Song Y},
  year = {2020},
  journal = {Cancer biotherapy \& radiopharmaceuticals},
  doi = {10.1089/cbr.2019.3520},
  url = {https://doi.org/10.1089/cbr.2019.3520}
}

RIS

TY  - JOUR
TI  - Retracted: Naringenin Inhibits Cell Migration, Invasion, and Tumor Growth by Regulating circFOXM1/miR-3619-5p/SPAG5 Axis in Lung Cancer.
AU  - Tan Z
AU  - Sun Y
AU  - Liu M
AU  - Xia L
AU  - Cao F
AU  - Qi Y
AU  - Song Y
PY  - 2020
JO  - Cancer biotherapy & radiopharmaceuticals
DO  - 10.1089/cbr.2019.3520
UR  - https://doi.org/10.1089/cbr.2019.3520
ER  - 

APA

Z, T., Y, S., M, L., L, X., F, C., Y, Q., & Y, S. (2020). Retracted: Naringenin Inhibits Cell Migration, Invasion, and Tumor Growth by Regulating circFOXM1/miR-3619-5p/SPAG5 Axis in Lung Cancer.. Cancer biotherapy & radiopharmaceuticals. https://doi.org/10.1089/cbr.2019.3520

Source records